Cart
sales@molnova.com
VAL-083
CAS No. 23261-20-3
VAL-083( Dianhydrogalactitol | Dianhydrodulcitol )
Catalog No. M24063 CAS No. 23261-20-3
VAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 107 | In Stock |
|
| 5MG | 164 | In Stock |
|
| 10MG | 222 | In Stock |
|
| 25MG | 374 | In Stock |
|
| 50MG | 555 | In Stock |
|
| 100MG | 790 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVAL-083
-
NoteResearch use only, not for human use.
-
Brief DescriptionVAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
-
DescriptionVAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
-
In Vitro——
-
In Vivo——
-
SynonymsDianhydrogalactitol | Dianhydrodulcitol
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA Alkylator
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number23261-20-3
-
Formula Weight146.14
-
Molecular FormulaC6H10O4
-
Purity>98% (HPLC)
-
SolubilityDMF :90 mg/mL (615.85 mM);H2O:40 mg/mL (273.71 mM; Need ultrasonic)
-
SMILESO[C@H]([C@H](O)[C@@]1([H])OC1)[C@@]2([H])CO2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kaiji Hu, et al. Abstract 811: VAL083, a novel N7 alkylating agent, surpasses NSC 362856 activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme. Cancer Research. 2012 Mar 31-Apr 4.
molnova catalog
related products
-
SW155246
SW155246 is a potent and selective inhibitor of DNMT1 (DNA methyltransferase 1; IC50 of 1.2 μM).
-
GSK-3484862
Gsk-3484862 is a non covalent inhibitor of DNA methyltransferase DNMT1 with anticancer activity. Gsk-3484862 mediates the global demethylation of mouse embryonic stem cells.
-
Sarmustine
Sarmustine (SarCNU) is an alkylating agent with anticancer activity that inhibits the growth of prostate cancer cells via p53-dependent and p53-independent pathways.
